http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018529946-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57411 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-901 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2016-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2018529946-A |
| titleOfInvention | Cancer detection method |
| abstract | The present disclosure relates to a method for determining whether a subject has cancer. More particularly, the present disclosure relates to a method for determining whether a subject has cancer when a pathological assessment of cell morphology is negative for cancer. More particularly, the present disclosure relates to a method for determining whether morphologically normal cells are malignant. When the pathological assessment of cell morphology is negative for cancer, the identification of malignant cells is based on detecting the binding of anti-telomerase antibodies to clinically important cells. [Selection figure] None |
| priorityDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.